tiprankstipranks
Astria Therapeutics (ATXS)
NASDAQ:ATXS

Astria Therapeutics (ATXS) Financial Statements

1,022 Followers

Astria Therapeutics Financial Overview

Astria Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.321; its P/E ratio is -4.82; Astria Therapeutics is scheduled to report earnings on August 5, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -19.93M$ -17.73M$ -12.57M$ -11.19M-
EBITDA$ -19.93M$ -17.73M$ -12.57M$ -11.19M-
Net Income Common Stockholders$ -19.93M$ -17.73M$ -12.57M$ -11.19M-
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 369.91M$ 188.81M$ 202.96M$ 213.33M$ 226.44M
Total Assets$ 378.81M$ 193.86M$ 207.05M$ 218.24M$ 230.63M
Total Debt$ 168.00K$ 488.00K$ 643.00K$ 794.00K$ 939.00K
Net Debt$ -369.74M$ -188.32M$ -202.31M$ -212.53M$ -225.50M
Total Liabilities$ 11.07M$ 9.38M$ 6.65M$ 6.88M$ 9.42M
Stockholders Equity$ 367.74M$ 184.48M$ 200.40M$ 211.36M$ 221.22M
Cash Flow-
Free Cash Flow$ -19.09M$ -14.26M$ -10.70M$ -13.26M-
Operating Cash Flow$ -19.09M$ -14.26M$ -10.70M$ -13.25M-
Investing Cash Flow$ -126.23M$ -4.00K$ -57.92M$ 194.99M-
Financing Cash Flow$ 141.81M$ 110.00K$ 273.00K$ 37.00K-
Currency in USD

Astria Therapeutics Earnings and Revenue History

Astria Therapeutics Debt to Assets

Astria Therapeutics Cash Flow

Astria Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis